{"slideshow_credits": null, "snippet": "Merck said the Food and Drug Administration had rejected an application for a new sleeping pill called suvorexant, but would probably approve it in smaller doses.", "abstract": null, "section_name": "Business Day", "print_page": "", "document_type": "article", "byline": {"person": [{"firstname": "Katie", "role": "reported", "lastname": "THOMAS", "rank": 1, "organization": ""}], "original": "By KATIE THOMAS", "contributor": ""}, "web_url": "http://www.nytimes.com/2013/07/02/business/fda-prefers-smaller-dosage-of-merck-sleep-drug.html", "lead_paragraph": "Merck said the Food and Drug Administration had rejected an application for a new sleeping pill called suvorexant, but would probably approve it in smaller doses.", "headline": {"main": "F.D.A. Prefers Smaller Dosage of Merck Sleep Drug"}, "_id": "51d1c6727e0d9c0839d2d5f0", "word_count": "313", "multimedia": [], "pub_date": "2013-07-02T00:00:00Z", "source": "The New York Times", "news_desk": "Business", "keywords": [{"value": "Merck & Company Inc", "name": "organizations", "is_major": "N", "rank": "1"}, {"value": "Drugs (Pharmaceuticals)", "name": "subject", "is_major": "N", "rank": "2"}, {"value": "Food and Drug Administration", "name": "organizations", "is_major": "N", "rank": "3"}, {"value": "Sleep", "name": "subject", "is_major": "N", "rank": "4"}], "blog": [], "subsection_name": null, "type_of_material": "News"}